ZOE.DE StockTwits Mentions

Track ZOE.DE's AI-powered predictions, market trends, and investment insights.

ZOE.DE AI Prediction ZOE.DE Sentiment ZOE.DE Reddit

Mock Tradesimulated, no real money

You don't hold ZOE.DE in your mock portfolio yet.

ZOE.DE StockTwits Mentions

Track ZOE.DE's AI-powered predictions, market trends, and investment insights.

ZOE.DE AI Prediction ZOE.DE Sentiment ZOE.DE Reddit

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)0.1%

Price (7d)0.4%

Volume vs avg0.3x

Reddit mentions vs 7D-2%

Volatility vs normal0.7x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

Low liquidity

Avg volume 3K — may be hard to exit

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~€66.16 (recent support level)

Reddit mentions decline for 3+ consecutive days

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

ZOE.DE AI Stock Analysis

Financial Performance

bullish

The combination of a relatively low PE ratio of 13.20 and a solid EPS of 5.27 suggests Zoetis is generating healthy earnings relative to its current share price. This points to strong underlying profitability and potentially undervalued earnings power if growth is sustained. While we lack full income-statement detail, the earnings metrics alone are supportive of a constructive view on financial performance.

PE ratio of 13.20 is modest for a profitable, established animal health company, implying the market is not aggressively pricing in growth and may be undervaluing earnings.
EPS of 5.27 indicates solid per‑share profitability, suggesting that the business is generating meaningful net income relative to its share count.
The combination of low‑to‑moderate valuation and strong EPS typically reflects a financially sound, cash‑generative business with room for multiple expansion if fundamentals remain intact.

Stock Price & Technicals

bearish

Despite an 8.4% gain in the last month, the stock is trading well below its 200‑day moving average of €103.75, at €69.54. This large gap indicates a prevailing longer‑term downtrend, with the recent bounce more consistent with a short‑term recovery than a confirmed reversal. Without evidence that price is reclaiming the long‑term moving average or that momentum is decisively turning, the technical picture remains cautious.

Current price of €69.54 is significantly below the 200‑day moving average of €103.75, signaling a dominant longer‑term downtrend and overhead resistance.
The 8.4% rise over the past month suggests improving short‑term sentiment but is not yet sufficient to negate the broader technical weakness.
In the absence of RSI data, the large discount to the 200‑day average implies the stock may be in a recovery phase from prior selling pressure rather than in a confirmed uptrend.

Alternative Data Signals

neutral

Alternative data for Zoetis shows steady but not explosive engagement and hiring. Web traffic and app downloads appear robust in absolute terms, while job openings and most social channels are flat to slightly up, indicating a stable operating posture rather than aggressive expansion. These signals collectively point to a healthy, mature franchise with incremental, not breakout, growth momentum.

Estimated 291,548 monthly website visitors and roughly 14,000 daily app downloads indicate solid digital reach and ongoing customer engagement, supportive of a stable demand base.
Job openings at 131 with 0.0% month‑over‑month growth suggest hiring is steady but not accelerating, consistent with operational stability rather than a major growth ramp.
Social media presence is large and mostly flat to modestly rising (e.g., LinkedIn at 620,881 followers flat, Instagram up 0.8%, Facebook up 0.2%), implying brand stability and gradual audience growth without strong viral or momentum effects.

Conclusion

neutral

Zoetis appears fundamentally sound and reasonably valued on earnings, but the stock’s position well below its 200‑day moving average tempers the outlook. Alternative data points to a stable, entrenched business with moderate digital and brand growth, yet not enough near‑term acceleration to override the current technical downtrend. Overall, the setup is balanced: fundamentally constructive but technically cautious, leading to a neutral stance.

Underlying profitability and valuation metrics are supportive, but the pronounced discount to the 200‑day moving average keeps the technical picture bearish.
Alternative data indicates a steady, mature business with solid engagement and hiring, reinforcing long‑term stability but not signaling strong short‑term upside catalysts.

AI Score

Hold

Alternative6

Fundamental8

Technical1

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold ZOE.DE in your mock portfolio yet.